Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17537235rdf:typepubmed:Citationlld:pubmed
pubmed-article:17537235lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17537235lifeskim:mentionsumls-concept:C0796392lld:lifeskim
pubmed-article:17537235lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:17537235lifeskim:mentionsumls-concept:C0023413lld:lifeskim
pubmed-article:17537235lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:17537235lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:17537235lifeskim:mentionsumls-concept:C0069717lld:lifeskim
pubmed-article:17537235lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:17537235lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:17537235lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:17537235pubmed:dateCreated2007-6-22lld:pubmed
pubmed-article:17537235pubmed:abstractTextTo evaluate the efficacy and the toxicity of front line FOLFOX4 combined with bevacizumab in patients with metastatsic CRC (mCRC).lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:languageenglld:pubmed
pubmed-article:17537235pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:citationSubsetIMlld:pubmed
pubmed-article:17537235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17537235pubmed:statusMEDLINElld:pubmed
pubmed-article:17537235pubmed:issn1471-2407lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:GeorgouliasVa...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:Emmanouilides...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:KalbakisKosta...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:MavroudisDimi...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:SouglakosJohn...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:AgelakiSofiaSlld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:AndroulakisNi...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:VamvakasLambr...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:Christophylak...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:TouroutoglouN...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:KalykakiAnton...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:KotsakisAthan...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:SfakiotakiGeo...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:DiamandidouEl...lld:pubmed
pubmed-article:17537235pubmed:authorpubmed-author:ChatzidakisAd...lld:pubmed
pubmed-article:17537235pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17537235pubmed:volume7lld:pubmed
pubmed-article:17537235pubmed:ownerNLMlld:pubmed
pubmed-article:17537235pubmed:authorsCompleteYlld:pubmed
pubmed-article:17537235pubmed:pagination91lld:pubmed
pubmed-article:17537235pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:meshHeadingpubmed-meshheading:17537235...lld:pubmed
pubmed-article:17537235pubmed:year2007lld:pubmed
pubmed-article:17537235pubmed:articleTitleFront-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.lld:pubmed
pubmed-article:17537235pubmed:affiliationDepartment of Medical Oncology, Interbalkan Medical Center, Thessaloniki, Greece. georgsec@med.uoc.gr <georgsec@med.uoc.gr>lld:pubmed
pubmed-article:17537235pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17537235pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17537235pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:17537235pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17537235lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17537235lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17537235lld:pubmed